HK1052137A1 - Stabilized ascorbic acid solutions. - Google Patents

Stabilized ascorbic acid solutions.

Info

Publication number
HK1052137A1
HK1052137A1 HK03104161A HK03104161A HK1052137A1 HK 1052137 A1 HK1052137 A1 HK 1052137A1 HK 03104161 A HK03104161 A HK 03104161A HK 03104161 A HK03104161 A HK 03104161A HK 1052137 A1 HK1052137 A1 HK 1052137A1
Authority
HK
Hong Kong
Prior art keywords
ascorbic acid
acid solutions
stabilized ascorbic
solutions
vitamin
Prior art date
Application number
HK03104161A
Other languages
English (en)
Inventor
Ghislain Vivier
Anthony Costa
Original Assignee
Vivier Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vivier Canada Inc filed Critical Vivier Canada Inc
Publication of HK1052137A1 publication Critical patent/HK1052137A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
HK03104161A 2000-09-08 2003-06-11 Stabilized ascorbic acid solutions. HK1052137A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23106800P 2000-09-08 2000-09-08
PCT/CA2001/001270 WO2002019972A2 (en) 2000-09-08 2001-09-10 Stabilized ascorbic acid solutions

Publications (1)

Publication Number Publication Date
HK1052137A1 true HK1052137A1 (en) 2003-09-05

Family

ID=22867624

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03104161A HK1052137A1 (en) 2000-09-08 2003-06-11 Stabilized ascorbic acid solutions.

Country Status (12)

Country Link
US (6) US7342045B2 (de)
EP (1) EP1265595B1 (de)
JP (2) JP4043942B2 (de)
AT (1) ATE297188T1 (de)
AU (1) AU775878C (de)
BR (1) BR0109780A (de)
CA (1) CA2396927C (de)
DE (1) DE60111362T2 (de)
ES (1) ES2243549T3 (de)
HK (1) HK1052137A1 (de)
MX (1) MXPA02008295A (de)
WO (1) WO2002019972A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0109780A (pt) * 2000-09-08 2003-01-21 Vivier Pharma Inc Soluções de ácido ascórbico estabilizadas; uso das mesmas; processo para sua obtenção e formulações compreendendo as mesmas
DE10301917B4 (de) * 2003-01-17 2007-02-01 Gerhard Saalmann Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren
CA2536283A1 (en) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. Pharmaceutical preparations having an improved solubility
ES2325590T3 (es) * 2004-01-13 2009-09-09 L'oreal Usa Creative, Inc. Composiciones de acido ascorbico estabilizadas y procedimientos para las mismas.
WO2006049088A1 (ja) * 2004-11-01 2006-05-11 Kaneka Corporation ポリエーテルの製造方法および重合体
US20070225360A1 (en) 2006-03-22 2007-09-27 L'oreal Anti-aging composition containing phloretin
WO2011085013A2 (en) * 2010-01-05 2011-07-14 Kaplan David L Vitamin c composition for use in the prevention and treatment of stretch marks, radiation dermatitis, and other skin conditions and methods of using the same
US20110217410A1 (en) * 2010-02-11 2011-09-08 Daniel Perlman Stabilized vitamin c in foods and beverages
GB201013680D0 (en) * 2010-08-14 2010-09-29 Chatfield Pharmaceuticals Ltd Stable vitamin c formulations
JP5627104B2 (ja) * 2011-02-04 2014-11-19 Ｍｔコスメティクス株式会社 アスコルビン酸を配合した溶液及びその溶液の製造方法
JP6045164B2 (ja) * 2012-03-27 2016-12-14 小林製薬株式会社 長命草ポリフェノール並びにビタミンｅ及び／又はビタミンｃを含む組成物
TR201809996T4 (tr) * 2012-04-20 2018-08-27 Dsm Ip Assets Bv Katı, rengi stabil l-askorbik asit bileşimleri.
WO2016163023A1 (ja) * 2015-04-10 2016-10-13 Ｍｔコスメティクス株式会社 美容液
WO2018003850A1 (ja) 2016-06-28 2018-01-04 ロート製薬株式会社 アスコルビン酸及び／又はその塩を含有する外用組成物
US20190298688A1 (en) * 2016-11-21 2019-10-03 Vivier Canada Inc. Putrescine slow-release topical formulations
US20210275495A1 (en) * 2017-06-23 2021-09-09 Vivier Canada Inc. Putrescine topical formulations
TW201944991A (zh) * 2018-03-30 2019-12-01 日商樂敦製藥股份有限公司 含有抗壞血酸以及/或是其鹽的外用組成物、以及防止外用組成物之著色以及/或是結晶之析出之方法
JP7344897B2 (ja) 2018-09-25 2023-09-14 ロート製薬株式会社 アスコルビン酸及び／又はその塩を含有する外用組成物
DE102018008512A1 (de) 2018-10-27 2020-04-30 Ilma biochem GmbH Herstellung, Zusammensetzung und Anwendung von Zubereitungen in einer Zweikammer-Auftragungsvorrichtung zur Neutralisierung und Inaktivierung von oxidierenden, ätzenden und reizenden Chemikalien auf der Haut
US10973749B2 (en) 2019-03-29 2021-04-13 L'oreal Cosmetic composition comprising vitamin C and ceramides
JP7378233B2 (ja) * 2019-06-26 2023-11-13 ロート製薬株式会社 アスコルビン酸又はその塩を含有する外用組成物
WO2023183563A1 (en) * 2022-03-25 2023-09-28 Curology, Inc. Compositions and methods of treating acne and photoaging
CN115152754B (zh) * 2022-07-25 2023-04-04 山东仕邦农化有限公司 一种用于液体制剂的复合稳定剂及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983382A (en) * 1987-01-27 1991-01-08 Avon Products, Inc. Cosmetic preparation incorporating stabilized ascorbic acid
US5093360A (en) * 1989-04-07 1992-03-03 Yu Ruey J Retinal, derivatives and their therapeutic use
US5140043A (en) * 1989-04-17 1992-08-18 Duke University Stable ascorbic acid compositions
US5935584A (en) * 1994-01-13 1999-08-10 Elizabeth Arden Company Vitamin C delivery system
FR2737122B1 (fr) * 1995-07-25 1997-09-12 Oreal Composition stable contenant de l'acide ascorbique
FR2740042B1 (fr) 1995-10-23 1997-11-14 Oreal Support, et composition contenant ce support et un actif cosmetique ou dermatologique stabilise
CN1202909A (zh) * 1995-11-27 1998-12-23 陶氏化学公司 含有束缚阳离子生成活化剂的负载型催化剂
US6162419A (en) * 1996-11-26 2000-12-19 Nicholas V. Perricone Stabilized ascorbyl compositions
EP0884045A1 (de) * 1997-06-06 1998-12-16 Pfizer Products Inc. Selbstbräunende Dihydroxyaceton Formulierungen mit verbesserter Stabilität und eine erhöte Abgabe erzeugend
US6124348A (en) * 1997-07-01 2000-09-26 Lawrence M. Wells Vitamin C skin formulations
US5869063A (en) * 1998-06-29 1999-02-09 Protease Sciences, Inc. Dermatological and cosmetic compositions containing marama bean extract
US6103267A (en) * 1998-07-27 2000-08-15 Sunsmart, Inc. Stabilized ascorbic acid, composition, and method of use
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US5972360A (en) * 1998-09-03 1999-10-26 Braun; Darian Self-tanning towelette
US6087393A (en) * 1999-06-10 2000-07-11 Igen, Inc. Stabilized vitamin C formulations
DE10009252A1 (de) * 2000-03-01 2001-09-06 Henkel Kgaa Wärmendes Hautreinigungsgel
BR0109780A (pt) * 2000-09-08 2003-01-21 Vivier Pharma Inc Soluções de ácido ascórbico estabilizadas; uso das mesmas; processo para sua obtenção e formulações compreendendo as mesmas

Also Published As

Publication number Publication date
US20060029687A1 (en) 2006-02-09
US20080125482A1 (en) 2008-05-29
JP4043942B2 (ja) 2008-02-06
AU775878C (en) 2005-04-07
US20140148509A1 (en) 2014-05-29
US9687471B2 (en) 2017-06-27
ATE297188T1 (de) 2005-06-15
WO2002019972A3 (en) 2002-09-06
DE60111362D1 (de) 2005-07-14
US20170252321A1 (en) 2017-09-07
ES2243549T3 (es) 2005-12-01
US20180263956A1 (en) 2018-09-20
WO2002019972A2 (en) 2002-03-14
EP1265595B1 (de) 2005-06-08
JP2007238625A (ja) 2007-09-20
MXPA02008295A (es) 2004-12-03
BR0109780A (pt) 2003-01-21
AU775878B2 (en) 2004-08-19
EP1265595A2 (de) 2002-12-18
CA2396927C (en) 2004-07-20
US8053469B2 (en) 2011-11-08
AU8945201A (en) 2002-03-22
US20110319486A1 (en) 2011-12-29
DE60111362T2 (de) 2006-07-20
CA2396927A1 (en) 2002-03-14
JP2004507561A (ja) 2004-03-11
US7342045B2 (en) 2008-03-11

Similar Documents

Publication Publication Date Title
HK1052137A1 (en) Stabilized ascorbic acid solutions.
DK1200418T3 (da) Nematodicide trifluorbutener
PL352318A1 (en) Fish serine proteinases, and pharmaceutical and cosmetic use of same
DE60112330D1 (en) Pyrazolopyridinderivate
YU12903A (sh) Derivati aminoalkenilbenzoil-benzofurana ili benzotiopena, postupak za njihovo pripremanje i kompozicije koje ih sadrže
HK1068274A1 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence
UA49884C2 (uk) ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
AU5915100A (en) Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
WO2002010152A3 (de) Neue indolderivate und deren verwendung als arzneimittel
MXPA03001536A (es) (aminoalcoxibenzoil) benzofuranos o benzotiofenos, metodo para preparar los mismo y composiciones que los contienen.
CA2266759A1 (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
ATE256392T1 (de) Verwendung von polyaminosäurederivate als konservierungsmittel
MXPA03001455A (es) Compuestos de pirazol, composiciones farmaceuticas y metodos para modular o inhibir la actividad del amiloide-beta-peptido asociado a reticulo endoplasmico y l-3-hidroxiacil-coa-deshidrogenasa.
BR0012751A (pt) Benzofuranos serotonérgicos
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
MXPA03010737A (es) Aril-8-azabiciclo(3.2.1) octanos para tratamiento de depresion.
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
AU2001284154A1 (en) Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
AU6722498A (en) Disubstituted biphenyloxazolines
MXPA03003466A (es) Derivados de piranosido.
PL365687A1 (en) Novel trioxepan compounds
WO2001092205A3 (en) Stabilization of amido acids with antioxidants
UA33493A (uk) Розчин для кислотної обробки свердловин
UA38157A (uk) Засіб для вибілювання зубів, уражених флюорозом

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190910